drugset / Trial / NCT02478879

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

NCT02478879

Phase 1 Completed 24 enrolled Zosano Pharma Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine which of two delivery methods of Parathyroid Hormone (PTH) is preferred by patients after 14 days of use for each.

Timeline

Start
2015-06
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Parathyroid Hormone Protein / enzyme biologic 20 ug Other
Subject Parathyroid Hormone Protein / enzyme biologic 40 ug Other